FASN catalyzes the conversion of malonyl-coenzyme A (CoA) and acetyl-CoA into palmitic acid, a 16-carbon chain saturated fatty acid that acts as a precursor of fatty acids, thus giving tumor cells a proliferative advantage (Ventura et al. 2015). The gene discussed is FASN; the disease is neoplasm.